News

Health insurers and pharma companies are striking pay-for-results deals under which rebates are offered if a drug does not perform as well in the real world as in clinical trials

Digital health start-up VitalSignum is on track to launch Beat2Phone, a small mobile device that detects arrhythmia by measuring the patient’s ECG, with the first production batch due to be on the market early next month.

A broad package of initiatives includes €50M for a pilot of a new European Cybersecurity Research and Competence Centre to train specialists and an EU-wide cyber security certification scheme